The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
40
No.
01
January 03, 2014
- Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics
- Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites
- An Appreciation: Janet Rowley, “Translational Research Pioneer”
- In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology
TCL
Vol.
40
No.
02
January 10, 2014
- Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida
- Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy
- Ludwig Cancer Research Donates $540 Million to Six Centers
- AVEO’s Tizozanib Fails in Colorectal Cancer
- Task Force Issues Guidless on LDCT Lung Screening
- ACS: Decline in Death Rates Saved Over 1.3 Million Lives
- In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research
- FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination
TCL
Vol.
40
No.
03
January 17, 2014
- Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic
- As Leadership Changes Continue, Fontaine, Leach Get New Posts
- NIH, NCI Get Higher Funding In 2014 Budget
- CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts
- Howard Hughes Medical Institute Seeks up to 25 New Researchers
- In Brief: Baylor Campus to Build Joint Cancer Center
TCL
Vol.
40
No.
04
January 24, 2014
- Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS
- ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure
- Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions
- FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease
TCL
Vol.
40
No.
05
January 31, 2014
- Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications
- IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes
- President Calls For Reversing Cuts to Basic Research Budget
- Drasga, Einhorn Make Appeal For Single-Payer Healthcare
- ACS, SU2C Committ $20 Million For Lung Cancer Dream Team
- In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer
- FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat
CCL
Vol.
37
No.
1
January 31, 2014
- Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial
- Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival
- Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk
- Patients on Hypertension Meds Lived Longer, Analysis Shows
- Post-Hoc Analysis of ThermoDox Suggests OS Improvement
- Study: Gene Assay Can Provide Valid Prognostic Information
- Studies of Oncotype DX Test Presented at ASCO Symposium
- MicroRNA Assay Detects Cancer Two Years Before LDCT in Study
- NCI CTEP Approved Trials For the Month of January
- FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination
TCL
Vol.
40
No.
06
February 07, 2014